CD28 and central nervous system cancer: Also, CAR-T cells directed to PDPN by a construct composed of NZ-1-based single-chain variable fragments and CD28, 4-1BB and CD3 ζ intracellular domains have shown good efficiency against glioma cells both in vitro and in vivo glioma xenografts (277).